Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Ropeginterferon ALFA-2B

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pint Pharma Gets ANVISA Nod For Besremi In Polycythemia Vera
    Pint Pharma Gets ANVISA Nod For Besremi In Polycythemia Vera

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250320323757/en/Pint-Pharma-Announces-ANVISAs-Approval-of-BESREMi-ropeginterferon-alfa-2b-for-the-Treatment-of-Polycythemia-Vera

    BUSINESSWIRE
    20 Mar 2025
    Share Share
    PharmaEssentia Highlights Bersremi Availability Amid Pegasys Shortage
    PharmaEssentia Highlights Bersremi Availability Amid Pegasys Shortage

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250304127897/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share
    Clinical Review of Pegylated Interferons Suggests Formulation
    Clinical Review of Pegylated Interferons Suggests Formulation

    21 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240221809028/en

    BUSINESSWIRE
    21 Feb 2024
    Share Share
    Presentations at MPN Congress Reinforce Role of ropeginterferon alfa-2b-njft
    Presentations at MPN Congress Reinforce Role of ropeginterferon alfa-2b-njft

    02 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231102403190/en

    BUSINESSWIRE
    02 Nov 2023
    Share Share
    Ropeginterferon Alfa-2b Produces Responses,Safety in Prefibrotic P Myelofibrosis
    Ropeginterferon Alfa-2b Produces Responses,Safety in Prefibrotic P Myelofibrosis

    30 Jun 2023

    // ONCLIVE

    https://www.onclive.com/view/ropeginterferon-alfa-2b-produces-responses-safety-in-prefibrotic-primary-myelofibrosis

    ONCLIVE
    30 Jun 2023
    Share Share
    PharmaEssentia Selects Pint-Pharma as Commercial Partner for BESREMi
    PharmaEssentia Selects Pint-Pharma as Commercial Partner for BESREMi

    02 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230602005191/en

    BUSINESSWIRE
    02 Jun 2023
    Share Share